Literature DB >> 26143348

A three-point time series study of antibiotic usage on an intensive care unit, following an antibiotic stewardship programme, after an outbreak of multi-resistant Acinetobacter baumannii.

S Singh1, Y Z Zhang, S Chalkley, K Ananthan, E Demertzi, M Beach, M Cohen, V Grover, C Chung, J Tatlock, N Soni, B Azadian.   

Abstract

Antibiotic use in intensive care units (ICUs) can promote antimicrobial resistance. Outbreaks of multi-resistant bacteria significantly affect patient outcomes and delivery of care. Antibiotic stewardship programmes (ASPs), combining root-cause analyses and multi-faceted prevention strategies, are necessary, often at significant cost and time. Which elements of such strategies have the largest impact on antibiotic usage following an outbreak is unclear. The aim of this study was to investigate how antibiotic usage in a university hospital ICU changed with a non-protocolised ASP following a disruptive outbreak of multi-resistant Acinetobacter baumannii (MRAB). This was a three time-period observational cohort study. The primary endpoint was the change in overall antibiotic usage (daily defined dose, DDD, antibiotic-days, antibiotic-courses) for consecutive ICU patients staying >48 h, over three 6-month study time periods pre-MRAB (2008, n = 84) and post-MRAB (2010, n = 88; 2012, n = 122). Secondary endpoints were changes in antibiotic usage and patient demographics, in predefined admission categories (Medical Emergency, ME; Surgical Elective, SEL; and Surgical Emergency, SE). The mean age (54.6 ± 17.7, 58.1 ± 17.9, 62.8 ± 19.1 years*) and severity of illness (APACHE 14.8 ± 8.0, 16.7 ± 6.8, 18.3 ± 6.1*) increased, particularly medical admissions. There was a sustained reduction in DDD antibiotic usage [1895.1 (2008), 1224.2 (2010), 1236.6 (2012) per 1000 patient-days] but no overall change in antibiotic-days or antibiotic-courses. Antibiotic usage (antibiotic-days) fell significantly in surgical emergency admissions [20.2 ± 32.1, 4.6 ± 7.4*, 5.9 ± 7.3]. There was a sustained drop in beta-lactam, quinolone, glycopeptide and macrolide usage. Following an MRAB outbreak, and subsequent operational changes including enhanced ASPs (non-protocolised), there was a sustained overall fall in antibiotic usage in spite of an increase in disease severity over 5 years.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26143348     DOI: 10.1007/s10096-015-2429-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.

Authors:  Håkan Hanberger; Dilek Arman; Hans Gill; Vlastimil Jindrák; Smilja Kalenic; Andrea Kurcz; Monica Licker; Paul Naaber; Elizabeth A Scicluna; Václav Vanis; Sten M Walther
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

Review 2.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

Review 3.  A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.

Authors:  James A McKinnell; Loren G Miller; Samantha J Eells; Eric Cui; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2013-08-19       Impact factor: 3.254

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  Cold air plasma to decontaminate inanimate surfaces of the hospital environment.

Authors:  Orla J Cahill; Tânia Claro; Niall O'Connor; Anthony A Cafolla; Niall T Stevens; Stephen Daniels; Hilary Humphreys
Journal:  Appl Environ Microbiol       Date:  2014-01-17       Impact factor: 4.792

6.  Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.

Authors:  Hao-Yuan Lee; Chyi-Liang Chen; Si-Ru Wu; Chih-Wei Huang; Cheng-Hsun Chiu
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

8.  Antibiotic consumption and resistance: data from Europe and Germany.

Authors:  Elisabeth Meyer; Petra Gastmeier; Maria Deja; Frank Schwab
Journal:  Int J Med Microbiol       Date:  2013-04-29       Impact factor: 3.473

9.  The rising problem of antimicrobial resistance in the intensive care unit.

Authors:  Nele Brusselaers; Dirk Vogelaers; Stijn Blot
Journal:  Ann Intensive Care       Date:  2011-11-23       Impact factor: 6.925

10.  Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.

Authors:  Evelien Assink-de Jong; Dylan W de Lange; Jos A van Oers; Maarten W Nijsten; Jos W Twisk; Albertus Beishuizen
Journal:  BMC Infect Dis       Date:  2013-04-16       Impact factor: 3.090

View more
  1 in total

1.  Evaluating the long-term impact of an antimicrobial stewardship programme in a Central London mixed medical and surgical intensive care unit.

Authors:  Shivani Singh; Rajiv Ark; Jason Tatlock; Sundhiya Mandalia; Christine Chung; Berge Azadian; Stephen Hughes; Nabeela Mughal; Luke S P Moore; Suveer Singh
Journal:  JAC Antimicrob Resist       Date:  2022-10-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.